Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium ferrous citrate is an orally active iron supplement used primarily for the treatment of iron deficiency anemia. It is a complex of iron(II) with sodium and citrate, designed to provide a source of divalent iron for hemoglobin synthesis while maintaining better gastrointestinal tolerability compared to traditional iron salts. Beyond its use in anemia, sodium ferrous citrate has been studied for its effects on mineral and bone disorder markers in patients with non-dialysis-dependent chronic kidney disease (CKD), where it has shown potential in reducing parathyroid hormone (PTH) levels. Furthermore, it is frequently investigated in combination with 5-aminolevulinic acid (5-ALA) to enhance mitochondrial function and immune responses, with clinical trials exploring its efficacy as a vaccine adjuvant for SARS-CoV-2 and as an adjunct treatment for uncomplicated malaria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium ferrous citrate.